<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2017-23-1-56-68</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-551</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>ПРЕДИКТОРЫ ИЗОЛИРОВАННЫХ И СОЧЕТАННЫХ АТЕРОСКЛЕРОТИЧЕСКИХ ПОРАЖЕНИЙ НА СУБКЛИНИЧЕСКОЙ СТАДИИ У МУЖЧИН СРЕДНЕГО ВОЗРАСТА И ИХ ВЗАИМОСВЯЗЬ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ</article-title><trans-title-group xml:lang="en"><trans-title>PREDICTORS OF SUBCLINICAL ISOLATED AND COMBINED ATHEROSCLEROTIC LESIONS IN MIDDLE-AGED MEN AND ITS CORRELATION WITH METABOLIC SYNDROME</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Найден</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nayden</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Найден Татьяна Викторовна — аспирант кафедры функциональной диагностики.</p><p>Ул. Кирочная, д. 41, Санкт-Петербург, 191015. Тел./факс: +7(812)275–19–33</p></bio><bio xml:lang="en"><p>Tatiana V. Nayden - MD, PhD Student, Department of Functional Diagnostics.</p><p>41 Kirochnaya street, St Petersburg, 191015. Phone/Fax: +7(812)275–19–33</p></bio><email xlink:type="simple">kazimir_gizm@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бартош‑Зеленая</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Bartosh‑Zelenaya</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бартош-Зеленая Светлана Юрьевна — доктор медицинских наук, профессор кафедры функциональной диагностики.</p><p>Ул. Кирочная, д. 41, Санкт-Петербург, 191015. Тел./факс: +7(812)275–19–33</p></bio><bio xml:lang="en"><p>Svetlana Yu. Bartosh-Zelenaya - MD, PhD, DSc, Professor, Department of Functional Diagnostics.</p><p>41 Kirochnaya street, St Petersburg, 191015. Phone/Fax: +7(812)275–19–33</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Плавинский</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Plavinskij</surname><given-names>S. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Плавинский Святослав Леонидович — доктор медицинских наук, заведующий кафедрой педагогики, философии и права.</p><p>Ул. Кирочная, д. 41, Санкт-Петербург, 191015. Тел./факс: +7(812)275–19–33</p></bio><bio xml:lang="en"><p>Sviatoslav L. Plavinskij - MD, PhD, DSc, Professor, Department of Pedagogy, Philosophy and Law.</p><p>41 Kirochnaya street, St Petersburg, 191015. Phone/Fax: +7(812)275–19–33</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Евсикова</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Evsikova</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Евсикова Ирина Александровна — аспирант кафедры функциональной диагностики.</p><p>Ул. Кирочная, д. 41, Санкт-Петербург, 191015. Тел./факс: +7(812)275–19–33</p></bio><bio xml:lang="en"><p>Irina A. Evsikova - MD, PhD Student, Department of Functional Diagnostics.</p><p>41 Kirochnaya street, St Petersburg, 191015. Phone/Fax: +7(812)275–19–33</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Северо-Западный государственный медицинский университет имени И. И. Мечникова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>North-Western Federal State Medical University named after I. I. Mechnikov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>06</day><month>03</month><year>2017</year></pub-date><volume>23</volume><issue>1</issue><fpage>56</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Найден Т.В., Бартош‑Зеленая С.Ю., Плавинский С.Л., Евсикова И.А., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Найден Т.В., Бартош‑Зеленая С.Ю., Плавинский С.Л., Евсикова И.А.</copyright-holder><copyright-holder xml:lang="en">Nayden T.V., Bartosh‑Zelenaya S.Y., Plavinskij S.L., Evsikova I.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/551">https://htn.almazovcentre.ru/jour/article/view/551</self-uri><abstract><p>Цель исследования — определить клинические, лабораторные и инструментальные предикторы изолированных и сочетанных атеросклеротических поражений артериального русла у мужчин среднего возраста на субклинической стадии и их взаимосвязь с компонентами метаболического синдрома.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Включено 194 мужчин среднего возраста (44–60 лет, ВОЗ, 2009) с верифицированным субклиническим атеросклеротическим поражением артерий одного и/или более артериальных бассейнов: коронарных артерий (КА), экстракраниальных артерий (ЭКА) и периферических артерий (ПА). Первую подгруппу составили 40 мужчин с изолированным поражением одного из артериальных бассейнов (средний возраст пациентов — 53,6 ± 4,7 года), из которых 17 человек имели поражение КА, 9 человек — ЭКА и 14 пациентов — ПА. Вторую подгруппу составили 154 пациента с сочетанным поражением в 2 и более артериальных бассейнах (средний возраст — 52,1 ± 4,1 года). Значимых различий по возрасту в рассматриваемых группах выявлено не было (р &gt; 0,05). Пациенты с перенесенными острым инфарктом миокарда и острым нарушением мозгового кровообращения в данный анализ не включались. Всем пациентам, помимо общеклинического осмотра, включавшего сбор анамнеза, физикальное обследование, измерение артериального давления (АД), индекса массы тела, проводился комплекс лабораторных (определение липидного спектра, показателей свертываемости крови, воспалительных маркеров), ультразвуковых (дуплексное сканирование сосудов по стандартной методике с использованием режимов энергетического и цветового допплеровского картирования и спектральным анализом кровотока), нагрузочных (стрессэхокардиография (стресс-ЭхоКГ), тредмил-тестирование) и ангиографических методов обследования. В качестве предполагаемых предикторов субклинического атеросклероза в модели логистической регрессии были проанализированы следующие показатели: уровень систолического и диастолического АД, общего холестерина, холестерина липопротеинов высокой плотности, триглицеридов, базальная концентрация глюкозы, уровень гомоцистеина, фибриногена, С-реактивного белка (СРБ), наличие курения в анамнезе и сердечно-сосудистых (СС) заболеваний у близких родственников, толщина комплекса интима-медиа (КИМ), общее время нагрузки и потребление кислорода в метаболических единицах при стресс-ЭхоКГ, а также прирост лодыжечно-плечевого индекса (ЛПИ) при тредмил-тестировании. результаты. Наиболее значимыми предикторами изолированного поражения КА служат наличие СС заболеваний у близких родственников, увеличение уровня СРБ и толщины КИМ, снижение толерантности к физической нагрузке и прироста глобальной сократимости при проведении стресс-ЭхоКГ; для ЭКА — наличие СС заболеваний в семейном анамнезе, увеличение уровня СРБ, АД и толщины КИМ; для артерий нижних конечностей (АНК) — гипергликемия и снижение прироста ЛПИ при тредмил-тестировании. Сочетанный субклинический атеросклероз наряду с артериальной гипертензией, дислипидемией и увеличением КИМ ассоциирован с отягощенным по СС заболеваниям семейным анамнезом, гипергомоцистеинемией (ГГЦ), увеличением уровня СРБ, снижением общего времени физической нагрузки, потребления кислорода и прироста глобальной сократимости при проведении стресс-ЭхоКГ, а также снижением или отсутствием прироста ЛПИ в тредмил-тесте. Проведенный анализ подтвердил наличие взаимосвязи субклинического сочетанного атеросклероза как с традиционными компонентами метаболического синдрома, так и с дополнительными параметрами — ГГЦ и повышением уровня СРБ.</p></sec><sec><title>Выводы</title><p>Выводы. Помимо известных взаимосвязей субклинического атеросклероза с артериальной гипертензией, дислипидемией и утолщением артериальной стенки, по нашим данным, предикторами изолированного поражения КА являются наличие СС заболеваний у близких родственников, увеличение уровня СРБ, снижение толерантности к физической нагрузке и прироста глобальной сократимости при проведении стресс-ЭхоКГ; поражения АНК — гипергликемия и снижение или отсутствие прироста ЛПИ на фоне физической нагрузки. Наличие одновременного поражения нескольких артериальных бассейнов на субклинической стадии можно предполагать при сочетании ГГЦ и увеличения уровня СРБ со снижением толерантности к физической нагрузке при проведении cтресс-ЭхоКГ и тредмил-тестирования.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To determine clinical, laboratory and instrumental predictors of subclinical isolated and combined atherosclerotic lesions in middle-aged men and its association with metabolic syndrome. design and methods. We examined 194 middle-aged men (44–60 years, WHO, 2009) with subclinical atherosclerotic arterial lesions: coronary artery (CA), extracranial artery (ECA) and peripheral artery (PA). The 1st subgroup included 40 men with isolated lesion in one arterial region (mean age — 53,6 ± 4,7 years): 17 subjects had CA lesion, 9 had ECA involvement, and 14 patients had PA lesion. The 2nd subgroup included 154 patients with combined lesions of 2 or more vascular pools (mean age — 52,1 ± 4,1 years). Both groups were comparable by age. Past acute myocardial infarction and stroke were exclusion criteria. All subjects underwent general clinical examination (medical history, physical examination, blood pressure (BP) and body mass index assessment), blood tests (lipids, coagulogram, inflammatory markers), ultrasonography (duplex scanning, power and color Doppler and spectral analysis of blood flow), stress-testing (stress-echocardiography, treadmill-test) and angiographic methods. The following parameters were analyzed in a logistic regression model as predictors of subclinical atherosclerosis: systolic and diastolic BP, total cholesterol, high-density lipoprotein cholesterol, triglycerides, basal and postprandial glucose level, homocysteine, fibrinogen, C-reactive protein (CRP), smoking and cardiovascular (CV) heredity factors, intima-media (IMT) thickness, total duration of exercise test and oxygen intake (MET) at stressechocardiography, and change of the ankle-brachial index (ABI) at treadmill-test. </p></sec><sec><title>Results</title><p>Results. The most significant predictors of isolated CA atherosclerosis are the following: cardiovascular disease in close relatives, increased CRP and IMT, decreased exercise tolerance and increment of ejection fraction during stress-echocardiography, ECA — family CV history, increased CRP and IMT, for PA — hyperglycemia and reduction in ABI increase at the peak exercise. Combined subclinical atherosclerotic lesions were associated with family CV history, hyperhomocysteinemia, increased CRP, decrease of the total duration of stress-test, oxygen intake and increment of ejection fraction during stress-echocardiography, as well as decreased ABI elevation at the treadmill test. Combined subclinical atherosclerosis is also associated with traditional and additional components of metabolic syndrome (hyperhomocysteinemia and increased CRP). </p></sec><sec><title>Conclusions</title><p>Conclusions. Besides to the known association with arterial hypertension, dyslipidemia, vascular wall thickening, the following predictors of isolated arterial lesions were found: for CA — with family CV history, increased CRP, decreased exercise tolerance, and increment of ejection fraction at stress-echocardiography, for ECA — family CV history, increased CRP, for PA — hyperglycemia and decreased ABI elevation at the peak exercise. Subclinical multifocal atherosclerosis is closely associated with hyperhomocysteinemia, increased CRP and reduced exercise tolerance at stress-tests.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>предикторы атеросклероза</kwd><kwd>артериальная гипертензия</kwd><kwd>субклинический атеросклероз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>predictors of atherosclerotic lesion</kwd><kwd>arterial hypertension</kwd><kwd>subclinical atherosclerosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347–60.</mixed-citation><mixed-citation xml:lang="en">Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347–60.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H et al. Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population. J Hypertens. 2009; 27(12):2351–2357.</mixed-citation><mixed-citation xml:lang="en">Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H et al. Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population. J Hypertens. 2009; 27(12):2351–2357.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Jaffer FA, O’Donnell CJ, Larson MG, Chan SK, Kissinger KV, Kupka MJ et al. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2012; 22(5):849–854.</mixed-citation><mixed-citation xml:lang="en">Jaffer FA, O’Donnell CJ, Larson MG, Chan SK, Kissinger KV, Kupka MJ et al. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2012; 22(5):849–854.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O’Leary D et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 2014;139(12): 1164–1179.</mixed-citation><mixed-citation xml:lang="en">Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O’Leary D et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 2014;139(12): 1164–1179.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Комаров А. Л., Панченко Е. П. Частота поражений различных сосудистых бассейнов и медикаментозное лечение больных с высоким риском атеротромботических осложнений. Российские результаты международного исследования AGATA. Кардиология. 2004;44(11):39–44. [Komarov AL, Panchenko EP. Incidence rate of various vascular beds impairment and pharmacological treatment of patients at high risk of atherothrombotic complications. Russian Results of International Trial AGATHA. Kardiologiia. 2004;44(11):39–44. In Russian].</mixed-citation><mixed-citation xml:lang="en">Комаров А. Л., Панченко Е. П. Частота поражений различных сосудистых бассейнов и медикаментозное лечение больных с высоким риском атеротромботических осложнений. Российские результаты международного исследования AGATA. Кардиология. 2004;44(11):39–44. [Komarov AL, Panchenko EP. Incidence rate of various vascular beds impairment and pharmacological treatment of patients at high risk of atherothrombotic complications. Russian Results of International Trial AGATHA. Kardiologiia. 2004;44(11):39–44. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Matheny M, McPheeters ML, Glasser A, Mercaldo N, Weaver RB, Jerome RN et al. Systematic review of cardiovascular disease risk assessment tools. Vanderbilt Evidence-based Practice Center. 2011; 85:12–21.</mixed-citation><mixed-citation xml:lang="en">Matheny M, McPheeters ML, Glasser A, Mercaldo N, Weaver RB, Jerome RN et al. Systematic review of cardiovascular disease risk assessment tools. Vanderbilt Evidence-based Practice Center. 2011; 85:12–21.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Berger JS, Jordan CO, Lloyd-jones D, Blumenthal RS. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol. 2010; 55(12):1169–77.</mixed-citation><mixed-citation xml:lang="en">Berger JS, Jordan CO, Lloyd-jones D, Blumenthal RS. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol. 2010; 55(12):1169–77.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA et al. 2010 ACCF/AHA Guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010; 122(25):584–636.</mixed-citation><mixed-citation xml:lang="en">Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA et al. 2010 ACCF/AHA Guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010; 122(25):584–636.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Den Ruijter HM, Peters SA, Todd J, Anderson TJ, Britton AR, Dekker JM et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a metaanalysis. J Am Med Assoc. 2012;308(8):796–803.</mixed-citation><mixed-citation xml:lang="en">Den Ruijter HM, Peters SA, Todd J, Anderson TJ, Britton AR, Dekker JM et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a metaanalysis. J Am Med Assoc. 2012;308(8):796–803.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O’Leary D et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate risk individuals. J Am Med Assoc. 2012;308(8):788–795.</mixed-citation><mixed-citation xml:lang="en">Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O’Leary D et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate risk individuals. J Am Med Assoc. 2012;308(8):788–795.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM et al. Arterial stiffness and cardiovascular events: The Framingham Heart Study. Circulation. 2010;121(4):505–511.</mixed-citation><mixed-citation xml:lang="en">Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM et al. Arterial stiffness and cardiovascular events: The Framingham Heart Study. Circulation. 2010;121(4):505–511.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Национальные рекомендации по ведению пациентов заболеваниями брахиоцефальных артерий (Российский согласительный документ). М.: Изд-во НЦССХ им. А. Н. Бакулева РАМН, 2013. 72 с. [National guidelines on management of patients with brachiocephalic lesions (Russian consensus document). Moscow: Publishing House of Bakulev National Centre of Cardiovascular Surgery, 2013. 72 p. In Russian].</mixed-citation><mixed-citation xml:lang="en">Национальные рекомендации по ведению пациентов заболеваниями брахиоцефальных артерий (Российский согласительный документ). М.: Изд-во НЦССХ им. А. Н. Бакулева РАМН, 2013. 72 с. [National guidelines on management of patients with brachiocephalic lesions (Russian consensus document). Moscow: Publishing House of Bakulev National Centre of Cardiovascular Surgery, 2013. 72 p. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mancia G, Fagart R, Narkiewicz K, Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–2219.</mixed-citation><mixed-citation xml:lang="en">Mancia G, Fagart R, Narkiewicz K, Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–2219.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N et al. Carotid intima-media thickness consensus (2004–2006). Cerebrovasc Dis. 2007;23(1):75–80.</mixed-citation><mixed-citation xml:lang="en">Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N et al. Carotid intima-media thickness consensus (2004–2006). Cerebrovasc Dis. 2007;23(1):75–80.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Peters SA, den Ruijter HM, Grobbee DE, Bots ML. Results from a carotid intima-media thickness trial as a decision tool for launching a large-scale morbidity and mortality trial. Circ Cardiovasc Imaging. 2013;1(6):20–25.</mixed-citation><mixed-citation xml:lang="en">Peters SA, den Ruijter HM, Grobbee DE, Bots ML. Results from a carotid intima-media thickness trial as a decision tool for launching a large-scale morbidity and mortality trial. Circ Cardiovasc Imaging. 2013;1(6):20–25.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lang RM, Badano RP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for cardiac chamber quantification by echocardiography in adults. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–70.</mixed-citation><mixed-citation xml:lang="en">Lang RM, Badano RP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for cardiac chamber quantification by echocardiography in adults. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–70.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation. 2011;123(5):551–565.</mixed-citation><mixed-citation xml:lang="en">Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation. 2011;123(5):551–565.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Windecker S, Kolh P, Alfonso F, Collet JP et al. 2014 ESC/ EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2013; 1;35(37):2541–619.</mixed-citation><mixed-citation xml:lang="en">Windecker S, Kolh P, Alfonso F, Collet JP et al. 2014 ESC/ EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2013; 1;35(37):2541–619.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37 (29):2315–2381.</mixed-citation><mixed-citation xml:lang="en">Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37 (29):2315–2381.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Alberti KG, Eckel RH, Grundi SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes Federation Task Forse on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2014;120 (16):1640–1645.</mixed-citation><mixed-citation xml:lang="en">Alberti KG, Eckel RH, Grundi SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes Federation Task Forse on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2014;120 (16):1640–1645.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem. 2011;276(38):35867–35874.</mixed-citation><mixed-citation xml:lang="en">Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem. 2011;276(38):35867–35874.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mei W, Rong Y, Jinming L, Yongjun L, Hui Z. Effect of homocysteine interventions on risk of cardiocerebrovascular events: a meta-analysis of randomized controlled trials. Circulation. 2010; 122(2):140–141.</mixed-citation><mixed-citation xml:lang="en">Mei W, Rong Y, Jinming L, Yongjun L, Hui Z. Effect of homocysteine interventions on risk of cardiocerebrovascular events: a meta-analysis of randomized controlled trials. Circulation. 2010; 122(2):140–141.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Сидоренко Б. А., Алехин М. Н., Азизов В. А., Сальников Д. В., Рустамова Я. К. Значение стресс-эхокардиографии у пациентов с ангиографически неизмененными коронарными артериями. Кардиология. 2008;12:4–9. [Sidorenko BA, Alekhin MN, Azizov VA., Salnikov DV, Rustamova YaK. The role of stress-echocardiography in patients with intact coronary arteries verified by coronary angiography. Kardiologiia. 2008;12:4–9. In Russian].</mixed-citation><mixed-citation xml:lang="en">Сидоренко Б. А., Алехин М. Н., Азизов В. А., Сальников Д. В., Рустамова Я. К. Значение стресс-эхокардиографии у пациентов с ангиографически неизмененными коронарными артериями. Кардиология. 2008;12:4–9. [Sidorenko BA, Alekhin MN, Azizov VA., Salnikov DV, Rustamova YaK. The role of stress-echocardiography in patients with intact coronary arteries verified by coronary angiography. Kardiologiia. 2008;12:4–9. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Сумин А. Н., Щеглова А. В., Федорова Н. В. Оценка сердечно-лодыжечного сосудистого индекса при кардиоваскулярных заболеваниях. Методические рекомендации. Кемерово, 2014. 41 с. [Sumin AN, Shcheglova AV, Fedorova NV. Evaluation of cardio-ankle index in cardiovascular disease. Textbook. Kemerovo, 2014. 41 p. In Russian].</mixed-citation><mixed-citation xml:lang="en">Сумин А. Н., Щеглова А. В., Федорова Н. В. Оценка сердечно-лодыжечного сосудистого индекса при кардиоваскулярных заболеваниях. Методические рекомендации. Кемерово, 2014. 41 с. [Sumin AN, Shcheglova AV, Fedorova NV. Evaluation of cardio-ankle index in cardiovascular disease. Textbook. Kemerovo, 2014. 41 p. In Russian].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
